Coronavirus 2019
The current Covid-19 pandemic underscores the requirement for multi-faceted modes of antiviral treatments, preventative strategies and countermeasures.
Nutri-Pharm supports research into new technologies such as platforms and delivery systems for active anti-viral compounds, whether they be known pharmaceutical compounds, natural components or blends, or novel molecules. As more data becomes available as to which active component profiles are likely to be useful against coronavirus, areas of potential value are expected to emerge.
Nutri-Pharm observes and encourages self-isolation and social distancing in accordance with governmental and medical requirements, whilst remaining fully active and operational.